------------------------------------------------------------------------------- TITLE: Tinnitus SOURCE: Dept. of Otolaryngology, UTMB, Grand Rounds DATE: 24 November 1991 RESIDENT PHYSICIAN: Joseph Bradfield, M.D. FACULTY: Chester L. Strunk, M.D. DATABASE ADMINISTRATOR: Melinda McCracken, M.S. ------------------------------------------------------------------------------- "This material was prepared by resident physicians in partial fulfillment of educational requirements established for the Postgraduate Training Program of the UTMB Department of Otolaryngology/Head and Neck Surgery and was not intended for clinical use in its present form. It was prepared for the purpose of stimulating group discussion in a conference setting. No warranties, either express or implied, are made with respect to its accuracy, completeness, or timeliness. The material does not necessarily reflect the current or past opinions of members of the UTMB faculty and should not be used for purposes of diagnosis or treatment without consulting appropriate literature sources and informed professional opinion." I. INTRODUCTION A. Definition: The perception of sound without an external acoustic stimulus. It may be caused by a wide variety of anatomic and pathologic abnormalities. It should be noted that tinnitus is a symptom of a great number of disease processes, therefore all patients deserve a full head and neck examination. B. Prevalence: It is estimated that from 15-32% of adults have had tinnitus at some point, and about 5 percent are severely disabled by their tinnitus. C. Epidemiology: 1. Male/Female ratio = 1, with a peak incidence in 50-70 year olds, declining after that. 2. Majority report tinnitus is constant. 3. Over 85% report tinnitus of < 10dB SL. 4. Most patients also have hearing loss, with 50% of profoundly deaf students complaining of tinnitus - usually in the better ear. 5. The pitch of tinnitus may correlate with pathology. II. CLASSIFICATION A. Objective versus Subjective Tinnitus: Tinnitus was previously grouped into subjective (audible only to the patient) and objective (audible to the examiner). However, it is more useful to classify tinnitus by etiology. Some clues to probable origin may be obtained from the patients characterization of his tinnitus - with pulsations implying a vascular origin, clicking and popping a myogenic origin, and constant noises arising in the inner ear. B. Otoacoustic Emissions: This refers to signals thought to be generated by the contractile activity of the outer hair cells of the cochlea and propagated into the ear canal via the ossicles and tympanic membrane. Otoacoustic emissions may be detected by using sensitive microphones placed in the external auditory canal. The level of emission varies up to 35 db SPL, and the signals are characteristically narrow band signals between 1.2 and 4.7 KHz. In general, otoacoustic emissions are inaudible to the patient, but Penner estimates that in 4% of tinnitus sufferers otoacoustic emissions cause the patients tinnitus. Identification of these patients is considered important in that aspirin can abolish these emissions - and may relieve tinnitus if a non-ototoxic dose can be established. C. Vascular Tinnitus: A history of pulsatile tinnitus which is usually synchronous with heartbeat suggests vascular origin. Vascular tinnitus may be further divided into: 1. Arterial: Most commonly resulting from atherosclerotic plaques in the internal carotid artery. Other causes include A-V fistulae/malformations (the most common AVM causing pulsatile tinnitus is between the occipital artery and the transverse sinus), aneurysms, persistent stapedial artery and aberrant internal carotid artery. Conductive hearing loss may attenuate background noises, bringing attention to the pulsatile tinnitus. 2. Nonarterial: Venous hums result from irregularity of flow in the jugular veins due to compression from the transverse process of C2. In addition, jugular bulb abnormalities, elevated ICP, and vascular neoplasms may cause pulsatile tinnitus. D. Muscle Contraction Tinnitus: Results from synchronous contractions of the muscles of the middle ear, eustachian tube and palate. Palatal myoclonus is usually faster than heart rate - 60 to 200 per minute - and is described as an objectively audible clicking sound. Sonotubometry studies indicate that the sound heard may be the click of the eustachian tube walls during relaxation. TMJ dysfunction may also cause tensor tympani spasm. Stapedial and palatal myoclonus may result from multiple sclerosis, intracranial neoplasm, cerebrovascular disease or may be psychogenic. Myoclonus persists during sleep. E. External and Middle Ear Tinnitus: As previously mentioned, conductive hearing loss (e.g. from infection, effusion, cerumen and especially otosclerosis) may attenuate background noise and result in tinnitus. Cerumen, foreign bodies and hairs may lie against the TM and cause tinnitus. Some place the patulous eustachian tube in a separate category of respiratory tinnitus. Here, the patient complains of a rushing or blowing sound with respiration. Myringotomy and tube placement, sclerosing agents at the tube orifice and diathermy of the orifice may be effective treatment. F. Peripheral Sensorineural Tinnitus: Peripheral tinnitus is localized to one or both ears, while central tinnitus is more poorly defined and may be heard all over the head. Eighty-five percent of the patients with tinnitus have some form of hearing loss. Many hypotheses have been proposed regarding the pathophysiology of peripheral tinnitus. Two of the most commonly accepted are: 1. Alteration in the spontaneous discharge rate of auditory fibers - the auditory system has one of the highest spontaneous discharge rates in the body. Drugs that increase the spontaneous discharge rate (e.g. salicylates) may cause tinnitus in this way. Others have suggested that an alteration in efferent inhibitory neurons firing rate may result in increased firing of adjacent afferent neurons which could be perceived as tinnitus. Such could be the case where acoustic trauma or Meniere's disease has resulted in an area of local hair cell damage. In an effort to improve sound detection, efferent inhibitory neurons might decrease their firing in an effort to increase local sound reception. Because the area of dis-inhibition is spread over an adjacent area the hyperactivity of hair cells adjacent to the damaged area could be percieved as tinnitus - in a frequency close too the area of damage ( the so-called edge effect). This is supported by the observation that patients with high pitch, noise induced hearing loss usually have high pitched tinnitus, and that patients with Meniere's disease often complain of low pitched tinnitus. 2. Tonndorf proposed in 1980 that decoupling of the stereocilia from the tectorial membrane could result in an increase in "noise" from that area. This could result from degenerative processes or from noise trauma. Multiple pathologic processes may cause peripheral tinnitus: 1. Noise Exposure may be the most common cause. In Vernon's study tinnitus associated with noise exposure is typically high-pitched and constant. With continued noise exposure SNHL becomes worse as does tinnitus. Early in the course there is SNHL at 4 kHz (noise notch) but recovery at higher frequencies. This is lost as condition worsens. 2. Presbycusis is commonly encountered in practice. The hearing loss is downward sloping high frequency, usually with associated high frequency tinnitus. 3. Head Trauma may result in tinnitus which is not noticed until some time after injury. It may be on the side of, or on the side opposite to trauma. It frequently increases in intensity initially and then gradually resolves. 4. Acoustic Neuroma presents with tinnitus in 10% of the cases. Tinnitus may be constant or intermittent, and may or may not be associated with hearing loss. 5. Meniere's Disease - Tinnitus one of the three cardinal symptoms of disease. It is typically low pitched (median 300 hz) and rumbling, unilateral, and may be intermittent especially early in course. Typically it is associated temporally with attacks of vertigo and hearing loss. Later in disease the tinnitus may become constant. 6. Otosclerosis may cause tinnitus both by its conductive component as well as by its involvement in the inner ear. Typically the tinnitus is low-medium pitch as in other conductive problems. 70-95% of patients with this disorder complain of tinnitus. 7. Drugs - many medications are known to cause tinnitus. It should be remembered that tinnitus is a common disorder, and may be related only temporally to medications. a. Aminoglycosides: may be high-pitched and associated mainly with drug-induced hearing loss. b. Quinine: permanent, high-pitched tinnitus. Very rare. c. Salicylates: Temporary tinnitus and mild reversible hearing loss. d. Diuretics: loop-inhibiting agents primarily responsible. May cause "screaming" tinnitus and significant permanent hearing loss. e. Others include caffeine, cocaine, marijuana and tobacco. 8. Other causes of peripheral tinnitus include metabolic diseases (e.g. hyperthyroidism, Diabetes), intracranial neoplasms and other CNS lesions (e.g. infections, MS). G. Central sensorineural tinnitus is usually described by patient as occurring "all over the head." Evidence for the central generation of auditory signals is found in the observation that patients who have undergone labyrinthectomy or eighth nerve section may still complain of tinnitus. The mechanism for central tinnitus is unknown, but again may lie in the change in firing rates of central inhibitory neurons (e.g. in the dorsal cochlear nucleus). Tumors of the central nervous system - especially the temporal lobe, and generalized head trauma are implicated. III. PATIENT EVALUATION A. History: An overall history of the patients health is obtained with emphasis on medications and habits. The patient should then describe the tinnitus including: 1. Quality of tinnitus: pitch, loudness, location, duration pattern (constant, pulsatile, intermittent). 2. Other otologic symptoms and history: hearing loss, vertigo, otorrhea, aural fullness, otalgia, infections, head trauma, noise exposure, ototoxic drug use. 3. Aggravating factors including fatigue, psychological stress, as well as sleep disturbance and the level of disability created by tinnitus. B. Physical Examination: All patients recieve a general head and neck examination with particular attention to neurologic and cardiovascular systems. The pinna, external canal and drum are inspected for clues to the origin of tinnitus. The mastoid, orbit, neck, skull and external auditory canal are auscultated with a stethoscope. Any sounds should be correlated with the patients pulse. Additional procedures: 1. The physician should determine if the tinnitus changes with head position. Venous hums are more common in younger women, and may be eliminated by gentle pressure on the internal jugular. Venous hums are worsened by Valsalva's maneuver, deep breathing and turning away from the afflicted ear, and lessened by turning toward the side affected. 2. AVMs in the mandible and maxilla may cause discoloration of the overlying skin or mucosa. 3. Palatal myoclonus may not be observable on intra-oral examination, and may be inhibited with the mouth open. If suspected, the palate may be observed with a flexible fiberoptic nasopharyngoscope. If careful search must also be made for other neurologic symptoms. 4. The TMJ should be palpated and auscultated, and a search made for other evidence of TMJ disease. The history and physical examination should give a good idea of the source of tinnitus, and the remainder of the workup may be tailored accordingly. In a patient with bilateral symmetric hearing loss and an appropriate history, limited additional workup would be indicated. C. Audiometric evaluation: A standard audiometric battery: puretone air and bone conduction, speech reception and discrimination, reflex testing (including decay) and impedance should be performed. Tympanometry may identify negative pressure associated with conductive losses, as well as to identify fluctuations in pressure associated with muscle twitching or pulsations. ABR may be indicated when retrocochlear pathology is suspected. Tinnitus matching allows a more precise definition of loudness and pitch - masking and residual inhibition may also be estimated. In general tinnitus is matched at about 3 - 4 db above threshold. About half of patients say their tinnitus is a single tone - in the other half the tinnitus resembles a narrow band noise in the 3000 - 5000 Hz range. Masking involves adjusting the intensity of external sound until it drowns out the tinnitus. Residual inhibition is the cessation of tinnitus after a sufficient masking stimulus. The usual length is 25 to 45 seconds. D. Laboratory studies: Patients with sensorineural tinnitus require routine laboratory studies to determine the source of their hearing loss. Studies include CBC, ESR, electrolytes, urinalysis, thyroid function and glucose tolerance tests, and serology for syphilis and collagen vascular diseases (ANA, Lupus prep, rheumatoid factor, and complement). E. Radiologic evaluation: CT and MRI are useful in evaluation of neoplasms and other soft-tissue lesions. Angiography and CT with contrast may be useful when tinnitus is thought to be due to vascular abnormalities. IV. TREATMENT A. Surgical Therapy: Once the etiology of tinnitus is established, specific therapy may be instituted. Surgical therapy is most effective in vibratory tinnitus and neoplasms: 1. Correction of lesions in vascular abnormalities sometimes affords relief e.g. jugular vein ligation, embolization of AVM, resection of glomus tumors. 2. Tensor veli palatini section, myringotomy and tube placement and ostium sclerosis has been advocated for patulous eustachian tube with mixed results and palatal myoclonus. Surgery is less effective in sensorineural tinnitus: 1. Results best in otosclerosis surgery: 75% of patients report improvement in tinnitus. 2. Various nerve sectioning procedures have been performed - retrolabyrinthine vestibular neurectomy, tympanosympathectomy, translabyrinthine cochleovestibular neurectomy, with variable results. However House reports in 500 translabyrinthine removals of acoustic neuromas with eighth nerve section that 50% remain the same or improve, and 50% worsen. B. Medical Therapy: Surgery has little place in the management of tinnitus in the absence of other pathologic conditions requiring treatment. Many medical therapies have been tried: 1. Anticonvulsants: Carbamazepine, primidone and phenytoin have been advocated based on theory that they will decrease neural hyperactivity. Limited by lack of effectiveness and side effects (bone marrow depression and hepatotoxicity). 2. Anti-dysrythymics and Local anesthetics: Up to 80% of patients respond to IV lidocaine with decrease or disappearance of tinnitus. A very small percentage have reported complete relief. Tocainide, an oral analog, is advocated by Shea who reports 46% improved. However, the drug has significant side effects at the required doses - CNS excitation and nausea, vomiting and anorexia. Flecainide has also been evaluated with disappointing results - only 23% of the patients reported improvement. 3. Vasodilators have been used to combat supposed local ischemia. Niacin family most widely used, but now falling into disfavor. Cerebral vasodilators such as carbon dioxide, histamine and papaverine have also been used without much success. 4. Antidepressants: Help some patients with clinical evidence of depression. May also have activity at neuronal level. C. Masking: Hippocrates noted masking effects of noise in 400's B.C. The effect is probably for two reasons: 1. A broad band noise is less irritating to the patient than their narrow band tinnitus. 2. Patients have control over the masking. Many tinnitus sufferers have developed their own masking techniques - running fans, faucets, air conditioners, or a poorly tuned radio. Several types of hardware available: 1. Hearing aid: provides good masking especially for those with tinnitus pitch in speech range. 2. Tinnitus masker: worn like hearing aid but produces only masking noise. 3. Tinnitus instrument: combination aid and masker with independently adjustable controls. Good for patients with hearing loss in same frequency range as their tinnitus. As noted, inhibition of tinnitus sometimes persists even after masking noise removed (residual inhibition). Improvement and continued use reported in from 5-50% of patients in different studies. Some concern has been raised because some maskers are powerful enough (>85 db) to produce additional hearing loss. No data are currently available, so patients should use the lowest setting which provides relief. D. Biofeedback: House reports that biofeedback training is effective in improving tinnitus in 80% of the patients who complete a training course. Biofeedback is effective in reducing anxiety and stress which may exacerbate tinnitus, and increases the ability of the patient to cope with his symptoms. E. Miscellaneous Treatments: 1. Electrical stimulation initially proposed in 1801 when Grapengiesser applied current to external canal. A positive DC current is most effective - especially when applied at the promontory or round window, but ultimately destroys hair cells and spiral ganglion cells. Portmann and Shulman initially had some success with stimulation of round window and transcutaneously but this not confirmed by recent studies. McKerrow, and House and Thedinger have used cochlear implant as analog for tinnitus instrument with some success. 2. Acupuncture: Multiple authors have found no benefit over placebo. 3. Hypnotherapy: Has been demonstrated to be a useful adjunct to relaxation training in some patients. 4. Allergy and Diet: Otolaryngic allergy affecting the inner, outer, or middle ear could possibly contribute to tinnitus. Allergy management in Meniere's disease patients brought on symptom relief in 30%. Other dietary constituents - notably coffee, tea, red wine, alcohol, cheese and chocolate have on occasion been implicated. The role of zinc in tinnitus generation has also been suspected by some. VI. SUMMARY AND CONCLUSIONS A. It is crucial that the physician bear in mind that tinnitus is a symptom and not a disease. Each patient requires a full evaluation for the etiology of his tinnitus. Specific disease entities identified should be treated, and patients must be given as much information as possible about the cause and potential treatment of their tinnitus. Extensive counseling is often required in those with disabling tinnitus. Stouffer recommends the following be covered with patients: 1. Tinnitus is a common condition usually associated with benign disease. 2. Tinnitus may increase with time. 3. It is unlikely the patient will become less annoyed by his tinnitus. 4. A log of times, places, and conditions which affect the tinnitus may be useful in managing the condition. 5. Ear/noise protection is important. 6. Patients with Meniere's disease may have more difficulties coping with tinnitus than others. B. Finally, patients should be encouraged to contact: The American Tinnitus Association P.O. Box 5 Portland Oregon 97207 ------------------------------------------------------------------------------- BIBLIOGRAPHY Alleva, M, Loch, WE, and Paparella, MM. Tinnitus. Primary Care. 1990. 17:289-97. Cummings, C. Otolaryngology. Vol. IV. Ch. 172. pp. 3201-3217. English, GM. Otolaryngology. Vol. I. Ch. 53. Fortnum, HM, and Coles, RRA. Trial of Flecainide in the Management of Tinnitus. Clinical Otolaryngology. 1991. 16:93-96. Fox, GN, and Baer, MT. Palatal Myoclonus in Children. Western Journal of Medicine. 1991. 154:98-102. Glasscock, ME, et al. An Analysis of the Retrolabyrinthine vs. the Retrosigmoid Vestibular Nerve Section. Otolaryngology, Head and Neck Surgery. 1991. 104:88-95. Hazell, JW, and Jastreboff, PJ. Tinnitus I: Auditory Mechanisms: a Model for Tinnitus and Hearing Impairment. Journal of Otolaryngology. 1990. 19:1-5. Hazell, JW. Tinnitus II: Surgical Management of Conditions Associated with Tinnitus and Somatosounds. Journal of Otolaryngology. 1990. 19:6-10. Hazell, JW. Tinnitus III: The Practical Management of Sensorineural Tinnitus. Journal of Otolaryngology. 1990. 19:11-18. House, JW. Tinnitus: evaluation and treatment. AJO. 1984. 5:472-475. House, JW. Therapies for Tinnitus. American Journal of Otology. 1989. 10:163-165. Levine, SB and Snow, JB. Pulsatile tinnitus. Laryngoscope. 1987. 97:401-405. Mattox, DE and Richtsmeier, WJ. Tinnitus: the initial evaluation. OHNS. 1987. 96:172-174. Mattox, DE, and Wilkins, SA. Tinnitus. American Academy of Otolaryngology-Head and Neck Surgery Instructional Package. Washington, DC. 1989. McKerrow, WS, et al. Tinnitus Suppression by Cochlear Implants. Annals of Otology, Rhinology and Laryngology. 1991. 100:552-558. Penner, MJ. An Estimate of the Prevalence of Tinnitus Caused by Spontaneous Otoacoustic Emissions. Archives of Otolaryngology, Head and Neck Surgery. 1990. 116:418-423. Paaske, PB, et al. Zinc in the Management of Tinnitus. Annals of Otology, Rhinology and Laryngology. 1991. 100:647-649. Spektor, Z, et al. Otoacoustic Emissions in Normal And Hearing Impaired Children and Normal Adults. Laryngoscope. 1991. 101:965- 976. Stouffer, JL, et al. Tinnitus as a Function of Duration and Etiology: Counseling Implications. American Journal of Otology. 1991. 12:188-194. Thedinger, BS, et al. Cochlear implant for tinnitus. Annals of Otology, Rhinology and Laryngology. 1985. 94:10-13. ---------------------------END------------------------------------------- TEST QUESTIONS - The following test questions are intended to provide proof to accrediting agencies that you have read and understood the entire Grand Rounds element. Your answers should be based on the text of the Grand Rounds element. Answers should be sent by e-mail addressed to fbquinn@utmb.edu. Answers can be sent by U.S Postal Service mail, using a plain sheet of paper on which the Grand Rounds element and the subscriber are fully identified. Correct answers will be transmitted to the subscriber via e-mail. Comments and alternative points of view should be expressed at the end of the list of the subscriber's answers. The University of Texas Medical Branch (UTMB) is accredited by the Accreditation Council For Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians. UTME designates this continuing medical education activity for 1 credit hour in Category 1 of the Physicians's Recognition Award of the American Medical Association. 1. Which of the following statements abouttinnitus is FALSE? a. It is the perception of sound without an external acoustic stimulus b. it is an only an annoying symptom that really needs no workup. c. It is a symptom of a great number of a number of disease processes and patients deserve a careful evaluation d. Subjective tinnitus is audible only to the patient 2. Which of the following is NOT associated with tinnitus? a. otosclerosis b. head trauma c. penicillin toxicity d. acoustic neuroma 3. Vascular causes of tinnitus are mostly associated with a. aberrant subclavian arteries b. berry aneurysm c. temporal arteritis d. plaques in the internal carotid artery 4. Which points are mostly important to elicit in the patient with tinnitus? a. pulsatile or steady character b. previous noise exposure c. hearing loss d. all of the above 5. Which of the following is not really essential to the examination for tinnitus: a. checking for postauricular lymphadenopathy b. auscultation of the common carotid arteries c. inspection of the pinna and ear canal d. listening to the mastoid bone, orbit, ear canal, and skull with the stethoscope 6. The most common pathologic process associated with peripheral tinnitus is a. liver disease b. industrial or military noise exposure c. cerebrovascular accident d. pituitary adenoma 7. The medications most likely to cause tinnitus are a. aminoglycosides b. loop diuretics c. salicylates including aspirin in large doses d. all of the above 8. The most effective treatment of persistent tinnitus is a. anti-arrythmics b. acupuncture c. stimulus masking agents d. anti-cholinergics In order for the sponsors of this CME activity to monitor its usefulness and appropriateness to subscribers, we ask that your supply answers to the following questions concerning the accompanying Grand Rounds Online CME segment: 1. Was the presentation organized in an acceptable manner? yes no opinion no 2. Was the material adequate to your continuing education needs with respect to content? yes no opinion no 3. Was the material appropriate to your clinical practice needs? yes no opinion no 4. Did you feel that the discussants' remarks were responsive to the issues presented in the body of the Grand Rounds segment? yes no opinion no 5. Do you consider the presentation to be timely with regard to current information available in both the lay press and the professional literature? yes no opinion no 6. Are the questions submitted with the Grand Rounds element meaningful in that they stimulate thought and perhaps further inquiry? yes no opinion no 7. Is the method of submitting the subscriber's answers to these questions expeditious and convenient? yes no opinion no 8. Would you recommend this method of completing the general requirment for Continuing Education Activity to your colleagues? yes no opinion no 10. How much money (U.S. dollars) would you be willing to pay for each award of 10 or more CME Category I credits earrned through this type of online CME activity? $100 $50 $25 $12.50 $6.25 $3.00 $1.50 $0.75 $0.35 $0.15 Please submit any comments, criticisms and suggestions which you may have in the space below. They will be given thoughtful consideration, especially if they are favorable comments, gentle criticisms, or constructive suggestions. 8-) /s/ The Editor. ================================================================== Francis B. Quinn, Jr., M.D. University of Texas Medical Branch Dept. of Otolaryngology Galveston, TX 77555-0521 Internet addresses: 409-772-2706, 772-2701 fbquinn@UTMB.edu 409-772-1715 FAX fbquinn@phil.utmb.edu ==================================================================